М.В. Шолкова, Э.А. Доценко
УО «Белорусский государственный медицинский университет»
Нарушение функции эндотелия рассматривается как одно из общих звеньев коморбидности пульмонологических и сердечно-сосудистых заболеваний. Цель работы: оценить динамику показателей функции эндотелия у пациентов с хроническими обструктивными заболеваниями легких в сочетании с артериальной гипертензией (АГ), ишемической болезнью сердца (ИБС) и гиперлипидемией на фоне приема аторвастатина.
ключевые слова: хроническая обструктивная болезнь легких, бронхиальная астма, дислипидемия, аторвастатин, эндотелиальная дисфункция
для цитирования: М.В. Шолкова, Э.А. Доценко. Эндотелиальная дисфункция при хронических обструктивных заболеваниях легких. Неотложная кардиология и кардиооваскулярные риски, 2019, Т. 3, № 1, С. 539–545
Endothelial dysfunction in chronic obstructive pulmonary diseases
M.V. Sholkava, E.A. Dotsenko
Endothelial dysfunction is considered as one of the links between pulmonary and cardiovascular diseases. To evaluate the dynamics of endothelial function in patients with dyslipidemia and chronic obstructive pulmonary diseases, receiving atorvastatin.
keywords: chronic obstructive pulmonary disease, asthma, dyslipidemia, atorvastatin, endothelial dysfunction
for references: M.V. Sholkava, E.A. Dotsenko. Endothelial dysfunction in chronic obstructive pulmonary diseases. Neotlozhnaya kardiologiya i kardioovaskulyarnye riski [Emergency cardiology and cardiovascular risks], 2019, vol. 3, no. 1, pp. 539–545
1. Guerra S. Asthma and chronic obstructive pulmonary disease. Curr Opin Allergy Clin Immunol, 2009, vol. 9, no. 5, рр. 409–416.
2. Diagnosis of Diseases of Chronic Airflow Limitation: Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS) [electronic resource]. Global Strаtegy for Asthma Management and Prevention, 2014. Available at: https://goldcopd.org/asthma-copd-asthma-copdoverlap-syndrome. (accessed 11.09.2017).
3. Rothnie K.J., Yan R., Smeeth L., Quint J.K. Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis [electronic resource]. BMJ Open, 2015, vol. 5, no. 9, e007824. Available at: https://www.ncbi.nlm.nih.gov/pubmed/26362660. (accessed 11.03.2018).
4. Tattersall M.C., Guo M., Korcarz C.E., Gepner A.D., Kaufman J.D., Liu K.J., Barr R.G., Donohue K.M., McClelland R.L., Delaney J.A., Stein J.H. Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol, 2015, vol. 35, no. 6, pp. 1520–1525.
5. Khaddaj M.R., Mathew J.C, Kendrick D.J., Braun A.P. The vascular endothelium: A regulator of arterial tone and interface for the immune system. Crit Rev Clin Lab Sci, 2017, vol. 54, no. 7-8, pp. 458–470.
6. Maruhashi T., Soga J., Fujimura N., Idei N., Mikami S., Iwamoto Y., Kajikawa M., Matsumoto T., Hidaka T., Kihara Y., Chayama K., Noma K., Nakashima A., Goto C., Tomiyama H., Takase B., Yamashina A., Higashi Y. Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study. Heart, 2013, vol. 99, no. 24, pp. 1837–1842.
7. Goldenberg N.M., Kuebler W.M. Endothelial cell regulation of pulmonary vascular tone, inflammation, and coagulation. Compr Physiol, 2015, vol. 5, no. 2, pp. 531–559.
8. Ambrosino P., Lupoli R., Iervolino S., De Felice A., Pappone N., Storino A., Di Minno M.N.D. Clinical assessment of endothelial function in patients with chronic obstructive pulmonary disease: a systematic review with meta-analysis. Intern Emerg Med, 2017, vol. 12, no. 6, pp. 877–885.
9. Dang H., Song B., Dong R., Zhang H. Atorvastatin reverses the dysfunction of human umbilical vein endothelial cells induced by angiotensin II. Exp Ther Med, 2018, vol. 16, no. 6, pp. 5286–5297.
10. Oesterle A., Laufs U., Liao J.K. Pleiotropic Effects of Statins on the Cardiovascular System. Circ Res, 2017, vol. 120, no. 1, pp. 229–243.
11. Margaritis M., Channon K.M., Antoniades C. Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering. Antioxid Redox Signal, 2014, vol. 20, no. 8, pp. 1198–1215.
12. Zhang L., Gong D., Li S., Zhou X. Meta-analysis of the effects of statin therapy on endothelial function in patients with diabetes mellitus. Atherosclerosis, 2012, vol. 223, no. 1, pp.78–85.
13. Chen J.H., Wu T., Yang L.K., Chen L., Zhu J., Li P.P., Hu X., Wang Y.H. Protective effects of atorvastatin on cerebral vessel autoregulation in an experimental rabbit model of subarachnoid hemorrhage. Mol Med Rep, 2018, vol. 17, no. 1, pp. 1651–1659.
14. Lo C.C.W., Moosavi S.M., Bubb K.J. The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary Hypertension. Front Physiol. 2018, vol. 23, no. 9, pp. 1167. doi: 10.3389/fphys.2018.01167.
